Overview

World Orphan Drug Alliance (WODA) is a global alliance of full-service regional distributors for orphan drugs. The alliance focuses on markets that are complex and often overlooked, but provide both, a pool of patients in need and potential funding opportunities for rare and specialized diseases. WODA's multi-territorial platform provides an alternative for pharma and biotech companies seeking a one-stop solution and comprehensive support for their products, ranging from named patient programs to full commercialization. Regions covered by WODA members: • Australia, New Zealand, South East Asia (Specialised Therapeutics) • Central and Eastern Europe (Medis) • China, Taiwan, Macau, Hong Kong (RareStone Group) • Greece, Cyprus, Malta (Path Pharma) • Israel (CTS) • Middle East, North Africa & Turkey (Vector Pharma) • Latin America (OrphanDC) • Russia & the CIS region (Orpharm) • Switzerland (EffRx Pharmaceuticals) WODA partner for global access, pricing and commercialization strategies: Decisive Consulting WODA provides pharmaceutical & biotech companies with rare disease portfolio: • Comprehensive support • Access to 200 million potential rare disease patients • Full-service solution • Deep understanding of local healthcare systems • Single point of contact for 152 countries • Flexible approach More about WODA: www.woda-alliance.com Get in touch with us: partners@woda-alliance.com